Browse the full record of transactions filed by MERRIFIELD C ANN, Director. Insider active across 2 companies, notably Lyra Therapeutics, Inc.. Aggregated, 8 reports have been published. Total volume traded: €88k. The latest transaction was filed on 10 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
C. Ann Merrifield is a Director at Lyra Therapeutics, Inc. and Flexion Therapeutics Inc. She plays an important role in the governance and strategy of these companies. Her expertise in biotechnology contributes to guiding strategic decisions and supporting innovation.